Mississauga, Canada

Robin Spencer


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robin Spencer

Introduction

Robin Spencer is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as serine protease inhibitors. With a total of 3 patents to his name, Spencer's work has the potential to impact various therapeutic applications.

Latest Patents

Among his latest patents are the inventions related to 2-oxy-4H-3,1-benzoxazin-4-ones and their related compounds. These compounds are particularly useful in pharmaceutical applications, as they are represented by the formula: ##STR1##. Additionally, he has developed pharmaceutical formulations of 2-oxy-4H-3,1-benzoxazin-4-ones, which are also represented by the formula: ##STR1##. These formulations include pharmaceutically acceptable acid addition salts, wherein 'a' is an integer ranging from 0 to 4.

Career Highlights

Robin Spencer is currently employed at Syntex (U.S.A.) Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of serine protease inhibitors in medicine.

Collaborations

Throughout his career, Spencer has collaborated with notable colleagues, including Alexander Krantz and Tim F Tam. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Robin Spencer's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…